Treatment of Aged Mice and Long-Term Durability of AAV-Mediated Gene Therapy in Two Mouse Models of LGMD

被引：0
|
作者：
Pozsgai, Eric R. [1 ]
Griffin, Danielle A. [1 ]
Peterson, Ellyn L. [1 ]
Kempton, Amber [1 ]
Rogers, Oliver [1 ]
Seo, Young-Eun [1 ]
Rodino-Klapac, Louise R. [1 ]
机构：
[1] Sarepta Therapeut Inc, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1137
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [1] Treatment of aged mice and long-term durability of AAV-mediated gene therapy in two mouse models of Limb girdle muscular dystrophy
    Pozsgai, E.
    Griffin, D.
    Peterson, E.
    Kempton, A.
    Rogers, O.
    Seo, Y.
    Rodino-Klapac, L.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S86 - S87
  • [2] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Fremuth, Leigh E.
    Hu, Huimin
    van de Vlekkert, Diantha
    Weesner, Jason A.
    Gomero, Elida M.
    d'Azzo, Alessandra
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 44 - 44
  • [3] AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
    Hu, Huimin
    Mosca, Rosario
    Gomero, Elida
    van de Vlekkert, Diantha
    Campos, Yvan
    Fremuth, Leigh E.
    Brown, Scott A.
    Weesner, Jason A.
    Annunziata, Ida
    d'Azzo, Alessandra
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 644 - 658
  • [4] AAV-Mediated Gene Therapy in Mouse Models of Recessive Retinal Degeneration
    Pang, J. -J.
    Lei, L.
    Dai, X.
    Shi, W.
    Liu, X.
    Dinculescu, A.
    McDowell, J. H.
    CURRENT MOLECULAR MEDICINE, 2012, 12 (03) : 316 - 330
  • [5] Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys
    Lai, CM
    Shen, WY
    Brankov, M
    Lai, YKY
    Barnett, NL
    Lee, SY
    Yeo, IYS
    Mathur, R
    Ho, JES
    Pineda, P
    Barathi, A
    Ang, CL
    Constable, IJ
    Rakoczy, EP
    MOLECULAR THERAPY, 2005, 12 (04) : 659 - 668
  • [6] AAV-mediated gene transfer of FKRP for therapy of LGMD2I
    Gicquel, E.
    Brown, S. C.
    Richard, I.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S59 - S59
  • [7] AAV-mediated gene transfer of FKRP for therapy of LGMD2I
    Gicquel, E.
    Faivre, M.
    Charrier, S.
    Martin, S.
    Brown, S.
    Richard, I.
    HUMAN GENE THERAPY, 2017, 28 (12) : A44 - A44
  • [8] AAV-mediated gene therapy in a mouse model of sialidosis
    van de Vlekkert, Diantha
    Hu, Huimin
    Weesner, Jason A.
    Gomero, Elida M.
    d'Azzo, Alessandra
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 129 - 130
  • [9] Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice
    Mochizuki, S
    Mizukami, H
    Ogura, T
    Kure, S
    Ichinohe, A
    Kojima, K
    Matsubara, Y
    Kobayahi, E
    Okada, T
    Hoshika, A
    Ozawa, K
    Kume, A
    GENE THERAPY, 2004, 11 (13) : 1081 - 1086
  • [10] Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice
    S Mochizuki
    H Mizukami
    T Ogura
    S Kure
    A Ichinohe
    K Kojima
    Y Matsubara
    E Kobayahi
    T Okada
    A Hoshika
    K Ozawa
    A Kume
    Gene Therapy, 2004, 11 : 1081 - 1086
12345